Theophylline sodium glycinate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for theophylline sodium glycinate and what is the scope of patent protection?
Theophylline sodium glycinate
is the generic ingredient in two branded drugs marketed by Cent Pharms and Novartis, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for theophylline sodium glycinate.
Summary for theophylline sodium glycinate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 20 |
Patent Applications: | 123 |
DailyMed Link: | theophylline sodium glycinate at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for theophylline sodium glycinate
US Patents and Regulatory Information for theophylline sodium glycinate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | ASBRON | theophylline sodium glycinate | TABLET;ORAL | 085148-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cent Pharms | SYNOPHYLATE | theophylline sodium glycinate | ELIXIR;ORAL | 006333-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |